Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial
Open Access
- 8 January 2008
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 98 (2) , 309-315
- https://doi.org/10.1038/sj.bjc.6604178
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancerBritish Journal of Cancer, 2006
- Phase II Study of Erlotinib in Patients With Advanced Biliary CancerJournal of Clinical Oncology, 2006
- Differential Cell Cycle–Regulatory Protein Expression in Biliary Tract Adenocarcinoma: Correlation With Anatomic Site, Pathologic Variables, and Clinical OutcomeJournal of Clinical Oncology, 2006
- Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II TrialJournal of Clinical Oncology, 2005
- Gemcitabine, 5‐fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinomaCancer, 2004
- Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyAnnals of Oncology, 2004
- Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trialBritish Journal of Cancer, 2002
- CorrespondenceEuropean Journal Of Cancer, 1998
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958